Literature DB >> 28577800

Patient Burden of Atopic Dermatitis.

Cathryn Sibbald1, Aaron M Drucker2.   

Abstract

Atopic dermatitis is associated with significant patient burden, with impacts from symptoms and visible physical manifestations of the disease. Consequences include detrimental effects on quality of life (QoL), sleep, self-esteem, interpersonal relationships, participation in leisure and sports, and attendance or performance at school or work. Patients also spend a significant amount of time on treatments and care. Worsening severity of disease appears to be associated with a higher risk of impaired QoL, and pharmacologic and educational interventions that improve disease severity appear to, for the most part, simultaneously improve QoL.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; Atopy; Burden; Eczema; Itch; Outcome measures; Quality of life; Sleep

Mesh:

Year:  2017        PMID: 28577800     DOI: 10.1016/j.det.2017.02.004

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  6 in total

1.  The role of the nurse in the care and management of patients with atopic dermatitis.

Authors:  Harmieke van Os-Medendorp; Elfie Deprez; Nele Maes; Sheila Ryan; Karina Jackson; Tonya Winders; Linda De Raeve; Christa De Cuyper; Steven Ersser
Journal:  BMC Nurs       Date:  2020-11-04

Review 2.  Breaking the Itch-Scratch Cycle: Topical Options for the Management of Chronic Cutaneous Itch in Atopic Dermatitis.

Authors:  Ian P Harrison; Fabrizio Spada
Journal:  Medicines (Basel)       Date:  2019-07-18

3.  Impact of the COVID-19 pandemic and lockdown on the clinical response to dupilumab treatment and the psychological status of non-infected atopic patients.

Authors:  Chiara Rovati; Mariateresa Rossi; Alessandra Gelmetti; Cesare Tomasi; Irene Calzavara-Pinton; Marina Venturini; Piergiacomo Calzavara-Pinton; Mariachiara Arisi
Journal:  Eur J Dermatol       Date:  2021-12-01       Impact factor: 3.328

4.  Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study.

Authors:  Andrew Alexis; Marjolein de Bruin-Weller; Stephan Weidinger; Weily Soong; Sebastien Barbarot; Ileana Ionita; Fan Zhang; Hernan Valdez; Claire Clibborn; Natalie Yin
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-17

5.  Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis.

Authors:  Jonathan I Silverberg; H Chih-Ho Hong; Jacob P Thyssen; Brian M Calimlim; Avani Joshi; Henrique D Teixeira; Eric B Collins; Marjorie M Crowell; Scott J Johnson; April W Armstrong
Journal:  Dermatol Ther (Heidelb)       Date:  2022-04-18

6.  What Is the Role of Night-Time Noise Exposure in Childhood Allergic Disease?

Authors:  A-Ram Kim; Jin-Hee Bang; Sung-Hee Lee; Jiho Lee
Journal:  Int J Environ Res Public Health       Date:  2022-02-26       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.